CPRC
CLX icon

Consolidated Portfolio Review Corp’s Clorox CLX Stock Holding History

Consolidated Portfolio Review Corp’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,916
Closed -$236K – 109
2025
Q3 		$236K Sell
1,916
-70
-4% -$8.69K 0.03% 413
2025
Q2 		$238K Buy
1,986
+30
+2% +$4K 0.03% 394
2025
Q1 		$288K Hold
1,956
– – 0.05% 308
2024
Q4 		$318K Buy
+1,956
New +$320K 0.05% 286
2023
Q2 		– Sell
-3,957
Closed -$626K – 319
2023
Q1 		$626K Buy
+3,957
New +$593K 0.17% 144

Other funds holding CLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Consolidated Portfolio Review Corp's CLX Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of Clorox (CLX) in Q4 2025, closing a stake of 1,916 shares — an estimated $236K sold.

Consolidated Portfolio Review Corp first reported a position in CLX in Q1 2023 and held it in 5 quarters. The position peaked at $626K in Q1 2023. 1,050 funds tracked by Wall St. Rank hold CLX as of Q4 2025.

  • Consolidated Portfolio Review Corp reported no remaining Clorox position as of Q4 2025 after selling out during the quarter.
  • Consolidated Portfolio Review Corp sold 1,916 Clorox shares in Q4 2025, an estimated $236K.
  • Consolidated Portfolio Review Corp first reported a position in Clorox in Q1 2023 and held it in 5 quarters.
  • Consolidated Portfolio Review Corp's Clorox position peaked at $626K in Q1 2023.
  • 1,050 funds tracked by Wall St. Rank held Clorox as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.